AU5939996A - Methods for evaluation of antimicrobial targets - Google Patents

Methods for evaluation of antimicrobial targets

Info

Publication number
AU5939996A
AU5939996A AU59399/96A AU5939996A AU5939996A AU 5939996 A AU5939996 A AU 5939996A AU 59399/96 A AU59399/96 A AU 59399/96A AU 5939996 A AU5939996 A AU 5939996A AU 5939996 A AU5939996 A AU 5939996A
Authority
AU
Australia
Prior art keywords
evaluation
methods
antimicrobial targets
antimicrobial
targets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59399/96A
Other languages
English (en)
Inventor
Bret Benton
Keith Bostian
Pamela Contag
Thomas R. Parr Jr.
Molly B. Schmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trine Pharmaceuticals Inc
Original Assignee
Microcide Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microcide Pharmaceuticals Inc filed Critical Microcide Pharmaceuticals Inc
Publication of AU5939996A publication Critical patent/AU5939996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU59399/96A 1995-06-07 1996-05-28 Methods for evaluation of antimicrobial targets Abandoned AU5939996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US482118 1990-02-20
US48211895A 1995-06-07 1995-06-07
PCT/US1996/007937 WO1996040979A1 (fr) 1995-06-07 1996-05-28 Procedes d'evaluation de cibles antimicrobiennes

Publications (1)

Publication Number Publication Date
AU5939996A true AU5939996A (en) 1996-12-30

Family

ID=23914751

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59399/96A Abandoned AU5939996A (en) 1995-06-07 1996-05-28 Methods for evaluation of antimicrobial targets

Country Status (4)

Country Link
EP (1) EP0830457A1 (fr)
AU (1) AU5939996A (fr)
CA (1) CA2223519A1 (fr)
WO (1) WO1996040979A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US7255851B2 (en) 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US5962249A (en) * 1995-12-22 1999-10-05 Microcide Pharmaceuticals, Inc. Sized-based marker identification technology
US6846625B1 (en) * 1998-01-09 2005-01-25 Cubist Pharmaceuticals, Inc. Method for identifying validated target and assay combination for drug development
US6878516B1 (en) * 1998-01-16 2005-04-12 Pharmacia & Upjohn Company Autoregulatory system for validating microbial genes as possible antimicrobial targets using a tetracycline-controllable element
WO1999036554A1 (fr) * 1998-01-16 1999-07-22 Pharmacia & Upjohn Company Systeme autoregulateur de validation de genes microbiens en tant qu'eventuelles cibles antimicrobiennes utilisant un element regulable par la tetracycline
US7449615B2 (en) 1998-12-17 2008-11-11 Xenogen Corporation Non-invasive evaluation of physiological response in a transgenic mouse
US6720139B1 (en) 1999-01-27 2004-04-13 Elitra Pharmaceuticals, Inc. Genes identified as required for proliferation in Escherichia coli
US6610503B1 (en) 1999-03-17 2003-08-26 Xenogen Corporation Animal models for predicting sepsis mortality
NZ515329A (en) 1999-05-05 2004-05-28 Tvw Telethon Inst Child Health Isolating biological modulators from biodiverse gene fragment libraries
GB9915399D0 (en) * 1999-07-02 1999-09-01 Zeneca Ltd Method
US6737245B1 (en) 1999-09-08 2004-05-18 Xenogen Corporation Luciferase expression cassettes and methods of use
US6589738B1 (en) 1999-11-09 2003-07-08 Elitra Pharmaceuticals, Inc. Genes essential for microbial proliferation and antisense thereto
US6867348B1 (en) 1999-12-16 2005-03-15 Xenogen Corporation Methods and compositions for screening for angiogenesis modulating compounds
IT1311335B1 (it) 1999-12-21 2002-03-12 Otc Optical Technologies Ct S Procedimento e dispositivo per realizzare reticoli in fibra ottica.
US7056728B2 (en) 2000-07-06 2006-06-06 Xenogen Corporation Compositions and methods for use thereof in modifying the genomes of microorganisms
JP2004530117A (ja) * 2001-02-22 2004-09-30 プラエシス ファーマシューティカルズ インコーポレーテッド 生物プロセスを調節するペプチドを同定する方法
WO2007097923A2 (fr) 2006-02-20 2007-08-30 Phylogica Limited Procede de construction et de criblage de bibliotheques de structures peptidiques
WO2023150176A1 (fr) * 2022-02-01 2023-08-10 Azitra Inc Expression du gène lekti humain à partir du chromosome de staphylococcus epidermidis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123526T1 (de) * 1987-08-17 1995-06-15 Hoffmann La Roche Hochreprimierbare expressionskontrollsequenzen.
FR2648149A1 (fr) * 1989-06-09 1990-12-14 Agronomique Inst Nat Rech Souches modifiees de bacteries phytophathogenes et leurs applications pour le criblage de molecules utilisables pour la protection des cultures
WO1996010579A1 (fr) * 1994-10-04 1996-04-11 New York University Blocage de l'expression des facteurs de virulence du staphylocoque dore

Also Published As

Publication number Publication date
EP0830457A1 (fr) 1998-03-25
WO1996040979A1 (fr) 1996-12-19
CA2223519A1 (fr) 1996-12-19

Similar Documents

Publication Publication Date Title
AU5939996A (en) Methods for evaluation of antimicrobial targets
AUPN426595A0 (en) Firearms
AU5426096A (en) Uses of antibacterial compounds
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU1354197A (en) Spherosiloxane coatings
AU4435396A (en) 4-aryl- and 4-heteroaryl -5-oxopyrazoline derivatives having pesticidal properties
AU6304196A (en) Substituted cyanophenyluracils
AU1195897A (en) Heteroarylcarboxamide derivatives
AU4086296A (en) Indolepiperidine derivatives
AU5645396A (en) Ascomycins
AU1464097A (en) Methods for sensing displacement using radar
EP0744628A3 (fr) Répondeur radar
AU5110296A (en) Arrangement for the detection of targets
AU7569196A (en) Herbicidal composition
AU6110496A (en) Phosphatase inhibitors
AU4437296A (en) Herbicidal composition
AU1278897A (en) Passification of zinc surfaces
AU6674796A (en) Wideband signal distribution system
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU6049796A (en) Lysyloxidase inhibitors
AU6304396A (en) Substituted carbonylaminophenyluracils
AU5101696A (en) Arrangement for the detection of targets
AU7415696A (en) Radar proximity detector
AU6622096A (en) Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
AU5825896A (en) Well inhibition